Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07799544 as a monotherapy or in combination for advanced solid tumors, including melanoma and gli…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating whole-body 124I-PET/CT dosimetry in patients with differentiated thyroid cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Pembrolizumab in High-risk Thyroid Cancer [Phase 2]
Phase 2 clinical trial update for pembrolizumab in high-risk differentiated thyroid cancer; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Decision Aid Efficacy in Low Risk Thyroid Cancer [NA]
This document provides an update on a clinical trial evaluating a decision aid for patients with low-risk thyroid cancer; the study is not y…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) [Phase 2]
Phase 2 trial update for selpercatinib in RET fusion differentiated thyroid cancer is currently recruiting (RAISE trial).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. [Phase 2]
A Phase 2 trial update for cabozantinib in advanced radioactive-iodine refractory differentiated thyroid cancer; the study is currently acti…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC) [Phase 2]
This is a Phase 2 trial comparing lenvatinib 24 mg/day versus 10 mg/day in patients with radioactive iodine–resistant differentiated thyroid…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Empirical Radioactive Iodine Therapy in DTC [Phase 1, Phase 2]
Clinical trial update for empirical radioactive iodine therapy in differentiated thyroid cancer, spanning Phase 1 and Phase 2, not yet recru…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers [NA]
University College London is conducting a trial comparing hemithyroidectomy and total thyroidectomy for low-risk differentiated thyroid canc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Lenvatinib in Locally Advanced Invasive Thyroid Cancer [Phase 2]
Phase 2 clinical trial of lenvatinib for locally advanced invasive thyroid cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer [NA]
A clinical trial sponsored by Ankara University is evaluating F-18 tetrafluoroborate PET/CT imaging for differentiated thyroid cancer and is…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
A Mayo Clinic-sponsored clinical study is evaluating the 18F-TFB PET/CT scan for imaging differentiated thyroid cancers; the trial is curren…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
A clinical trial evaluating thyroid hormone replacement after radioactive iodine therapy to determine its value and efficacy for differentia…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Iodine Uptake After a Low Iodine Diet [NA]
The document reports on a clinical study assessing iodine uptake after a low iodine diet in differentiated thyroid cancer. The trial is curr…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients [NA]
A clinical trial is testing a web-based program to help differentiated thyroid cancer patients manage radioactive iodine–related symptoms an…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer [Phase 1]
A Phase I study of Af-001 for differentiated thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer [Phase 3]
Phase 3 study evaluating dabrafenib plus trametinib in previously treated metastatic, radioactive iodine-refractory BRAF V600E–positive diff…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC [Phase 3]
Phase 3 trial evaluating desiccated thyroid extract combined with levothyroxine for TSH suppression in intermediate-to-high risk differentia…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Targeted Therapy to Increase RAI Uptake in Metastatic DTC
A clinical trial update announcing recruitment for a targeted therapy intended to increase radioiodine uptake in metastatic differentiated t…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether larotrectinib can enhance radioiodine uptake in differentiated thyroid cancer, including pedi…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer [Phase 2]
Phase II trial of tunlametinib in NRAS-mutant advanced thyroid cancer is currently recruiting, evaluating differentiated, poorly differentia…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of cyclophosphamide and sirolimus for metastatic, radioiodine-refractory differentiated th…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
A planned clinical trial to assess outcomes of radioactive iodine therapy (Iodine-131) in patients with differentiated thyroid cancer at low…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer [EARLY_Phase 1]
Early-phase clinical trial evaluating 177Lu-LNC1004 injection for FAP-positive, radioiodine-refractory differentiated thyroid cancer, curren…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: The EMIRATES Study
The EMIRATES Study, sponsored by Royal Marsden NHS Foundation Trust, is a recruiting clinical trial investigating treatment for differentiat…